Authors


Adeline Siew, PhD

Latest:

Developing Cannabis-Based Therapeutics

David Fulper, PhD, director of technology support at Catalent, shares insights on the challenges and opportunities for cannabis-based therapeutics.


Cynthia A. Challener

Latest:

Accessing Cannabinoids Using Biocatalysis

Efficient synthesis of complex cannabinoids is possible while avoiding marijuana cultivation.



Caroline Hroncich

Latest:

The Latest Challenges to Cannabis Analysis: Perspectives from Zacariah Hildenbrand

Our sister publication, LCGC International, sat down with Zacariah Hildenbrand, PhD, Chief Science Officer of Infinity Water Solutions and Partner of Medusa Analytical, for more insight into various trends in cannabis testing.



Ellutia

Latest:

Getting Started with GC Analysis for Cannabis

Want to begin cannabis testing but don’t know where to start? Register now to find out how even somebody with no previous GC experience can start in house testing of cannabis samples. On Demand webcast available until Jan. 31, 2019.



FRITSCH Milling & Sizing, Inc.

Latest:

Cannabis in Focus

The big challenge of supercritical CO2 extraction: the highest possible yield of the ingredients in the shortest possible time. This requires optimum, homogeneous grinding of the cannabis plant. No problem with FRITSCH technology.


Hamilton

Latest:

THC Metabolites in Urine v3

States that have legalized cannabis use also have a zero tolerance workplace drug policy that usually requires a urine test of known metabolites of THC.








Megan L'Heureux

Latest:

From the Editor: Time for Goodbye

A goodbye letter from former Group Editorial Director, Meg L'Heureux.


Phenomenex

Latest:

Expanded Mycotoxins Analysis in Cannabis Matrices by LC–MS/MS

An expanded list of 15 mycotoxins LC–MS/MS analysis is shown here with a simple solvent and modified QuEChERS salt extraction.


Agilent Technologies

Latest:

Building an Efficient Cannabis Testing Lab that Meets Compliance Standards

In an ever-evolving cannabis industry where regulatory compliance and accurate testing are paramount, staying ahead requires a deep understanding of how to build an efficient testing lab that meets compliance standards:



Cindy Orser

Latest:

New Study Links Cannabidiol’s Multitudinous Effects to Disruption of Cholesterol Homeostasis

Op-ed on a new study related to how cannabidiol (CBD) exerts its clinical efficacy.








Zacariah L. Hildenbrand

Latest:

Cannabis Pricing Crisis: Market Forces Shaping 2025 Trends

The volatility of wholesale cannabis prices marked by large fluctuations and regional disparities highlight the inherent instability still present in the cannabis marketplace. Adapting to shrinking margins and increased competitions is putting pressure on operators, causing them to adopt cost-cutting technologies, expand into edibles and extracts, and secure long-term supply agreements. Understanding these evolving dynamics is essential for companies to adapt, compete, and thrive in the industry.


Christian Sweeney

Latest:

How the Cannabis Industry Can Benefit from Leveraging Pharmaceutical Resources

Currently in the cannabis industry, the standards and benchmarks for drug delivery, analytics and testing, consumer reporting, and packaging are basic in nature with substantial room for more sophistication and technology. Here’s how it can be improved.



© 2025 MJH Life Sciences

All rights reserved.